ArticleFrontiers in oncology2019

Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines.

Claudia Fumarola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.